Serna Bio Analysis
What is Serna Bio?
Serna Bio is an AI-enabled drug discovery company developing small molecules targeting RNA to treat diseases with high unmet medical needs.
Employees
9
Founded
2021
Business Model
AI-driven drug discovery with revenue from partnerships and licensing agreements.
Product Features & Capabilities
- small molecules that modulate translation and splicing, validated drug targets, RNA architecture mapping, functional RNA motifs, unique chemical libraries, internal programs, external collaborations
Who are the founders of Serna Bio
RK
Rabia Khan
Founder
Market Focus
Serna Bio primarily focuses on the biotechnology industry, specifically in AI-enabled drug discovery aimed at developing small molecules for challenging-to-drug targets to treat diseases with high unmet medical needs.
Investors
- Amino Collective
- Backed VC
- Lifeforce Capital
- Y Combinator
- AME Cloud Ventures
- Hummingbird Ventures
Competitors Overview
Serna Bio operates in the competitive landscape of AI-enabled drug discovery, particularly focusing on small molecules that modulate translation and splicing. Its main competitors include:
- BioAge: This company leverages AI to identify and develop therapeutics that target aging-related diseas
See something that needs updating? Suggest edits to this profile.